People Behind the Science Podcast - Stories from Scientists about Science, Life, Research, and Science Careers
590: Investigating Inflammatory Diseases and Developing Novel Therapeutics - Dr. Luke O'Neill
Manage episode 283708450 series 2394067
Dr. Luke O'Neill is Professor and Chair of Biochemistry in the School of Biochemistry and Immunology at Trinity College Dublin. He is also an author of three popular science books, including the recently released book Never Mind the B#ll*cks, Here's the Science: A Scientist's Guide to the Biggest Challenges Facing Our Species Today. In addition, Luke co-founded Inflazome, a company dedicated to developing therapeutics to address unmet needs in inflammatory diseases. Luke is an immunologist. He studies the immune system, focusing mainly on inflammatory diseases like Crohn's disease, ulcerative colitis, rheumatoid arthritis, and Alzheimer’s disease. His lab aims to understand the underlying mechanisms of these diseases and develop new medicines to treat them. Recently, Luke’s lab has also been studying COVID-19 and potential therapeutics. In his free time, Luke enjoys music. He sings and plays guitar in a band called The Metabollix, and they have played a wide variety of gigs over the years, including at scientific conferences. He was awarded his B.A. in Natural Sciences with an emphasis in Biochemistry from Trinity College Dublin and his PhD in Pharmacology from the University of London. Afterwards he accepted a Medical Research Council postdoctoral fellowship to conduct research at Strangeways Research Laboratory in Cambridge. Luke has received numerous awards and honors for his exceptional research, including the Royal Dublin Society & The Irish Times Robert Boyle Medal for scientific excellence, the Royal Irish Academy Gold Medal for Life Sciences, and the European Federation of Immunology Societies Medal. Luke is also an elected Member of the Royal Irish Academy, a Member of the European Molecular Biology Organisation, and a Fellow of the Royal Society. In our interview, Luke shares more about his life and research.